Literature DB >> 1459546

The economic burden of mental illness.

D P Rice1, S Kelman, L S Miller.   

Abstract

Mental illness imposes a substantial burden on individuals and society. Using data from national surveys and a newly developed methodology for calculating costs, the authors estimate that in 1985 the total economic costs of mental illness were $103.7 billion. Of this total, direct treatment and support costs were $42.5 billion, or 11.5 percent of total personal health care spending for all illnesses. Morbidity costs--the value of reduced or lost productivity--amounted to $47.4 billion. Mortality costs--the lost value of productivity due to premature death resulting from mental illness--were estimated to be $9.3 billion, or 5.1 percent of total productivity losses for all deaths. Other related costs, including the cost of caregiver services, amounted to $4.5 billion.

Entities:  

Mesh:

Year:  1992        PMID: 1459546     DOI: 10.1176/ps.43.12.1227

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  17 in total

1.  Current approaches to identifying the severely mentally ill.

Authors:  M Slade; R Powell; G Strathdee
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-05       Impact factor: 4.328

Review 2.  Olanzapine. A pharmacoeconomic review of its use in schizophrenia.

Authors:  R H Foster; K L Goa
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

3.  Severe and persistent mental illness: a useful definition for prioritizing community-based mental health service interventions.

Authors:  Alberto Parabiaghi; Chiara Bonetto; Mirella Ruggeri; Antonio Lasalvia; Morven Leese
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-03-25       Impact factor: 4.328

Review 4.  Risperidone. A pharmacoeconomic review of its use in schizophrenia.

Authors:  R H Foster; K L Goa
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

5.  Cost of ambulatory care of diabetes mellitus: a study from north India.

Authors:  S Grover; A Avasthi; A Bhansali; S Chakrabarti; P Kulhara
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

6.  Impairment in role functioning in mental and chronic medical disorders in the United States: results from the National Comorbidity Survey Replication.

Authors:  B G Druss; I Hwang; M Petukhova; N A Sampson; P S Wang; R C Kessler
Journal:  Mol Psychiatry       Date:  2008-02-19       Impact factor: 15.992

7.  Overview and emerging trends.

Authors:  Sandeep Grover; Ajit Avasthi; Subho Chakrabarti; Paramanand Kulhara
Journal:  Indian J Psychiatry       Date:  2005-10       Impact factor: 1.759

8.  Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia.

Authors:  Rosaria Di Lorenzo; Alice Brogli
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

9.  The formal mental health care burden among recently deinstitutionalized patients.

Authors:  P Deb; A M Holmes
Journal:  J Behav Health Serv Res       Date:  1998-08       Impact factor: 1.505

10.  The cost of treating addiction from the client's perspective: results from a multi-modality application of the Client DATCAP.

Authors:  Kathryn E McCollister; Michael T French; Jeffrey M Pyne; Brenda Booth; Richard Rapp; Carey Carr
Journal:  Drug Alcohol Depend       Date:  2009-07-01       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.